Valikap Medical Technologies Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 30-12-2024
- Paid Up Capital ₹ 5.00 M
as on 30-12-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
About Valikap Medical Technologies
The Corporate was formerly known as Stem Medical Technology Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Anita Kurian, Balaraman Murali, Reny Jacob, and One other member serve as directors at the Company.
- CIN/LLPIN
U33110TN2011PTC080808
- Company No.
080808
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Valikap Medical Technologies?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anita Kurian  | Director | 26-May-2011 | Current |
| Balaraman Murali | Director | 26-May-2011 | Current |
| Reny Jacob | Director | 26-May-2011 | Current |
| Kurian Valikapathalil | Director | 26-May-2011 | Current |
Financial Performance of Valikap Medical Technologies.
Valikap Medical Technologies Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Valikap Medical Technologies?
In 2017, Valikap Medical Technologies had a promoter holding of 67.45% and a public holding of 32.55%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Transpace Technologies Private LimitedActive 16 years 1 monthBalaraman Murali and Kurian Valikapathalil are mutual person
Kurian Research Private LimitedActive 11 years 11 monthsAnita Kurian and Kurian Valikapathalil are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Valikap Medical Technologies?
Unlock and access historical data on people associated with Valikap Medical Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Valikap Medical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valikap Medical Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
